Mirae Asset Global Investments Co., Ltd. Novavax Inc Transaction History
Mirae Asset Global Investments Co., Ltd.
- $54.3 Billion
- Q1 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Novavax Inc stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 54,992 shares of NVAX stock, worth $761,639. This represents 0.0% of its overall portfolio holdings.
Number of Shares
54,992
Previous 99,314
44.63%
Holding current value
$761,639
Previous $476,000
44.96%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding NVAX
# of Institutions
246Shares Held
75.8MCall Options Held
5.06MPut Options Held
7.19M-
State Street Corp Boston, MA16.9MShares$234 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.5MShares$187 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.43MShares$131 Million0.0% of portfolio
-
Shah Capital Management8.12MShares$112 Million19.75% of portfolio
-
Geode Capital Management, LLC Boston, MA2.59MShares$35.8 Million0.0% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $1.08B
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...